Surgical implantation of STN-DBS leads using intraoperative MRI guidance: technique, accuracy, and clinical benefit at 1-year follow-up

Abstract

Background

Improvement of surgical accuracy during DBS-lead implantation has been described recently, leading to “frameless” or “MRI-verified“ techniques. However, combining a high-quality definition of the STN using intraoperative 1.5 MRI with the possibility to reduce errors due to co-registration and to monitor lead progression during surgical insertion while checking the absence of surgical complication is an appealing method. We report here surgical methodology, safety, application accuracy, and clinical benefit of STN-lead implantation under MRI guidance.

Methods

Two patients with a severe PD state were treated by bilateral STN–DBS. Leads were implanted under general anesthesia using intraoperative MRI guidance (ClearPoint system). Lead implantation accuracy was measured on T1 axial images at the level of the target. Clinical improvement was measured on the pre- and post-UPDRS 3 scale at 1-year follow-up.

Results

Surgery was safe and uneventful in both cases. Radial error was 0.36 (right) and 0.86 mm (left) in case 1, and 0.41 (right) and 0.14 mm (left) in case 2. No edema or hemorrhage were noticed.

Conclusions

Intraoperative MRI guidance allows DBS lead implantation with high accuracy and with great clinical efficacy. A larger cohort of patients is needed to confirm these initial results.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. 1.

    Anheim M, Batir A, Fraix V, Silem M, Chabardes S, Seigneuret E, Krack P, Benabid AL, Pollak P (2008) Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement: effects of reimplantation. Arch Neurol 65:612–616

    PubMed  Google Scholar 

  2. 2.

    Benabid AL, Chabardes S, Mitrofanis J, Pollak P (2009) Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 8:67–81

    Article  PubMed  Google Scholar 

  3. 3.

    Chabardes S, Polosan M, Krack P, Bastin J, Krainik A, David O, Bougerol T, Benabid AL (2013) Deep brain stimulation for obsessive–compulsive disorder: subthalamic nucleus target. World Neurosurg 80(S31):e31–e38

    Google Scholar 

  4. 4.

    Chhabra V, Sung E, Mewes K, Bakay RA, Abosch A, Gross RE (2010) Safety of magnetic resonance imaging of deep brain stimulator systems: a serial imaging and clinical retrospective study. J Neurosurg 112:497–502

    Article  PubMed  Google Scholar 

  5. 5.

    Dormont D, Ricciardi KG, Tande D, Parain K, Menuel C, Galanaud D, Navarro S, Cornu P, Agid Y, Yelnik J (2004) Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data. AJNR Am J Neuroradiol 25:1516–1523

    PubMed  Google Scholar 

  6. 6.

    Fraix V, Chabardes S, Krainik A, Seigneuret E, Grand S, Le Bas JF, Krack P, Benabid AL, Pollak P (2010) Effects of magnetic resonance imaging in patients with implanted deep brain stimulation systems. J Neurosurg 113:1242–1245

    Article  PubMed  Google Scholar 

  7. 7.

    Golombeck MA, Thiele J, Dossel O (2002) Magnetic resonance imaging with implanted neurostimulators: numerical calculation of the induced heating. Biomed Tech (Berl) 47(Suppl 1 Pt 2):660–663

    Article  Google Scholar 

  8. 8.

    Hariz MI (2002) Safety and risk of microelectrode recording in surgery for movement disorders. Stereotact Funct Neurosurg 78:146–157

    Article  PubMed  Google Scholar 

  9. 9.

    Henderson JM, Tkach J, Phillips M, Baker K, Shellock FG, Rezai AR (2005) Permanent neurological deficit related to magnetic resonance imaging in a patient with implanted deep brain stimulation electrodes for Parkinson's disease: case report. Neurosurgery 57:E1063, discussion E1063

    Article  PubMed  Google Scholar 

  10. 10.

    Hirabayashi H, Tengvar M, Hariz MI (2002) Stereotactic imaging of the pallidal target. Mov Disord 17(Suppl 3):S130–S134

    Article  PubMed  Google Scholar 

  11. 11.

    Holloway KL, Gaede SE, Starr PA, Rosenow JM, Ramakrishnan V, Henderson JM (2005) Frameless stereotaxy using bone fiducial markers for deep brain stimulation. J Neurosurg 103:404–413

    Article  PubMed  Google Scholar 

  12. 12.

    Kimmelman J, Duckworth K, Ramsay T, Voss T, Ravina B, Emborg ME (2011) Risk of surgical delivery to deep nuclei: a meta-analysis. Mov Disord 26:1415–1421

    Article  PubMed  Google Scholar 

  13. 13.

    Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345:91–95

    Article  CAS  PubMed  Google Scholar 

  14. 14.

    Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, du Montcel ST, Yelnik J, Chereau I, Arbus C, Raoul S, Aouizerate B, Damier P, Chabardes S, Czernecki V, Ardouin C, Krebs MO, Bardinet E, Chaynes P, Burbaud P, Cornu P, Derost P, Bougerol T, Bataille B, Mattei V, Dormont D, Devaux B, Verin M, Houeto JL, Pollak P, Benabid AL, Agid Y, Krack P, Millet B, Pelissolo A (2008) Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 359:2121–2134

    Article  CAS  PubMed  Google Scholar 

  15. 15.

    Movement, Disorder, Society, Task, Force, on, Rating, Scales, for, Parkinson’s, Disease (2003) The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 18:738–750

    Article  Google Scholar 

  16. 16.

    Nazzaro JM, Lyons KE, Wetzel LH, Pahwa R (2010) Use of brain MRI after deep brain stimulation hardware implantation. Int J Neurosci 120:176–183

    Article  PubMed  Google Scholar 

  17. 17.

    Schaltenbrand GWW (1977) Atlas for stereotaxy of the human brain, with an accompanying guide. Stuttgart

  18. 18.

    Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Halbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltete D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Kruger R, Pinsker MO, Amtage F, Regis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G (2013) Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 368:610–622

    Article  CAS  PubMed  Google Scholar 

  19. 19.

    Slavin KV, Thulborn KR, Wess C, Nersesyan H (2006) Direct visualization of the human subthalamic nucleus with 3T MR imaging. AJNR Am J Neuroradiol 27:80–84

    CAS  PubMed  Google Scholar 

  20. 20.

    Spetzger U, Hubbe U, Struffert T, Reinges MH, Krings T, Krombach GA, Zentner J, Gilsbach JM, Stiehl HS (2002) Error analysis in cranial neuronavigation. Minim Invasive Neurosurg 45:6–10

    Article  CAS  PubMed  Google Scholar 

  21. 21.

    Spiegel J, Fuss G, Backens M, Reith W, Magnus T, Becker G, Moringlane JR, Dillmann U (2003) Transient dystonia following magnetic resonance imaging in a patient with deep brain stimulation electrodes for the treatment of Parkinson disease. Case report. J Neurosurg 99:772–774

    Article  PubMed  Google Scholar 

  22. 22.

    Starr PA, Bejjani P, Lozano AM, Metman LV, Hariz MI (2011) Stereotactic techniques and perioperative management of DBS in dystonia. Mov Disord 26(Suppl 1):S23–S30

    Article  PubMed  Google Scholar 

  23. 23.

    Starr PA, Christine CW, Theodosopoulos PV, Lindsey N, Byrd D, Mosley A, Marks WJ Jr (2002) Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg 97:370–387

    Article  PubMed  Google Scholar 

  24. 24.

    Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS (2010) Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. J Neurosurg 112:479–490

    Article  PubMed Central  PubMed  Google Scholar 

  25. 25.

    Tagliati M, Jankovic J, Pagan F, Susatia F, Isaias IU, Okun MS (2009) Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage 47(Suppl 2):T53–T57

    Article  PubMed  Google Scholar 

  26. 26.

    Zrinzo L, Foltynie T, Limousin P, Hariz M (2012) Image-verified deep brain stimulation reduces risk and cost with no apparent impact on efficacy. Mov Disord 27:1585–1586, author reply 1586-1587

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Stephan Chabardes.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chabardes, S., Isnard, S., Castrioto, A. et al. Surgical implantation of STN-DBS leads using intraoperative MRI guidance: technique, accuracy, and clinical benefit at 1-year follow-up. Acta Neurochir 157, 729–737 (2015). https://doi.org/10.1007/s00701-015-2361-4

Download citation

Keywords

  • DBS
  • Subthalamic nucleus
  • MRI
  • Parkinson disease